Sandoz stock: AlphaValue downgrades Sandoz stock to Reduce

Published on 10/20/2026 at 15:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sales update is due October 27, 2026. Sandoz stock costs EUR 84.15 on October 20, 2026, up 1.80 percent versus the Tradegate close.

Analyst downgrade and reporting date

AlphaValue/Baader Europe downgraded Sandoz to Reduce on October 19, 2026.
Sandoz is scheduled to release third-quarter sales and revenue figures on October 27, 2026.
Sandoz stock costs EUR 84.15 at Lang & Schwarz on October 20, 2026 at 3:16 p.m. CEST, 1.80 percent above the Tradegate close.
Sandoz had a CHF 33.6 billion market capitalization on October 20, 2026.

Sandoz, CH1243598427, Illustration mit AI erstellt.

Sandoz Group AG (ISIN CH1243598427) faces a fresh rating setback after AlphaValue/Baader Europe downgraded the stock to Reduce on October 19, 2026, according to MarketScreener. Sandoz was trading at EUR 84.15 at Lang & Schwarz on October 20, 2026 at 3:16 p.m. CEST, up 1.80 percent versus the Tradegate close of October 19, 2026 at EUR 82.66.

October 27 brings the next test

The next scheduled operating update is the third-quarter sales and revenue release on October 27, 2026. The date is listed in the Sandoz calendar published by MarketScreener. That report will give investors a new reading on demand in generics and biosimilars after the first-half reporting period.

Stock sits below the Swiss high

The Swiss listing stood at CHF 77.76 on October 20, 2026 at 3:10 p.m. CEST. Its 52-week range was CHF 47.73 to CHF 77.86 on the same date, while the stock's year-to-date performance was plus 32.40 percent on October 19, 2026. Swiss trading volume reached 1,228,199 shares on October 19, 2026.

The current Swiss high leaves little room between the latest home-market quote and the 52-week peak. For investors, the October 27 sales update therefore provides the next concrete operating checkpoint, while the Reduce rating adds a more cautious research signal.

Valuation and peer comparison

Sandoz had a market capitalization of CHF 33.6 billion and a trailing price-to-earnings ratio of 63.31 on October 20, 2026. Its 2026 estimated price-to-earnings ratio was 35.20 and its estimated dividend yield was 1.16 percent, according to the valuation table dated October 20, 2026.

Comparison with peers

Sandoz: up 1.80 percent versus the Tradegate close, P/E 63.31, market capitalization CHF 33.6 billion.

Novartis (SIX, CHF): up 1.26 percent, P/E 23.25, market capitalization CHF 238.5 billion on October 20, 2026.

Roche Holding (SIX, CHF): up 0.24 percent, market capitalization USD 367.0 billion on October 19, 2026.

What comes next for the stock

The downgrade and the upcoming sales release point to two separate investor reference points: valuation today and operating delivery next week. The latest euro quote remains above the October 19 Tradegate close, while the Swiss listing is close to its 52-week high.

Sandoz was trading at EUR 84.15 at Lang & Schwarz on October 20, 2026 at 3:16 p.m. CEST, up 1.80 percent versus the Tradegate close of October 19, 2026 at EUR 82.66. The further course of trading is shown by the continuously updated real-time quote of Sandoz stock.